메뉴 건너뛰기




Volumn 31, Issue 4, 2016, Pages 541-547

The challenge of controlling phosphorus in chronic kidney disease

Author keywords

chronic kidney disease; clinical management; hyperphosphatemia; phosphate control

Indexed keywords

ALUMINUM HYDROXIDE; CALCITRIOL; CALCIUM ACETATE; CALCIUM CARBONATE; FERRIC CITRATE; FIBROBLAST GROWTH FACTOR 23; KLOTHO PROTEIN; LANTHANUM CARBONATE; MAGNESIUM CARBONATE; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT; PHOSPHORUS; SEVELAMER; SUCROFERRIC OXYHYDROXIDE; PHOSPHATE INTAKE;

EID: 84965116337     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv055     Document Type: Review
Times cited : (43)

References (56)
  • 1
    • 79953290820 scopus 로고    scopus 로고
    • 50 years of research and discovery in chronic kidney disease and mineral & bone disorder: The central role of phosphate
    • Slatopolsky E, Moe S. 50 years of research and discovery in chronic kidney disease and mineral & bone disorder: The central role of phosphate. Kidney Int Suppl 2011; 121: S1-S2
    • (2011) Kidney Int Suppl , vol.121 , pp. S1-S2
    • Slatopolsky, E.1    Moe, S.2
  • 2
    • 68949114585 scopus 로고    scopus 로고
    • KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
    • Moe SM, Drueke TB, Block G et al. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009; 76: S1-130
    • (2009) Kidney Int Suppl , vol.76 , pp. S1-S130
    • Moe, S.M.1    Drueke, T.B.2    Block, G.3
  • 3
    • 79957830094 scopus 로고    scopus 로고
    • Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population
    • Floege J, Kim J, Ireland E et al. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant 2011; 26: 1948-1955
    • (2011) Nephrol Dial Transplant , vol.26 , pp. 1948-1955
    • Floege, J.1    Kim, J.2    Ireland, E.3
  • 4
    • 79958133805 scopus 로고    scopus 로고
    • Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study
    • Naves-Diaz M, Passlick-Deetjen J, GuinsburgAet al. Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study. Nephrol Dial Transplant 2011; 26: 1938-1947
    • (2011) Nephrol Dial Transplant , vol.26 , pp. 1938-1947
    • Naves-Diaz, M.1    Passlick-Deetjen, J.2    Guinsburg, A.3
  • 5
    • 59949083708 scopus 로고    scopus 로고
    • Phosphorus and survival: Key questions that need answers
    • Cannata-Andia JB, Naves-Diaz M. Phosphorus and survival: key questions that need answers. J Am Soc Nephrol 2009; 20: 234-236
    • (2009) J Am Soc Nephrol , vol.20 , pp. 234-236
    • Cannata-Andia, J.B.1    Naves-Diaz, M.2
  • 6
    • 80053502175 scopus 로고    scopus 로고
    • Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition
    • Zoccali C, Ruggenenti P, Perna A et al. Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition. J Am Soc Nephrol 2011; 22: 1923-1930
    • (2011) J Am Soc Nephrol , vol.22 , pp. 1923-1930
    • Zoccali, C.1    Ruggenenti, P.2    Perna, A.3
  • 7
    • 79952604526 scopus 로고    scopus 로고
    • Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: A systematic review and meta-analysis
    • Palmer SC, Hayen A, Macaskill P et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: A systematic review and meta-analysis. JAMA 2011; 305: 1119-1127
    • (2011) JAMA , vol.305 , pp. 1119-1127
    • Palmer, S.C.1    Hayen, A.2    Macaskill, P.3
  • 8
    • 53749101804 scopus 로고    scopus 로고
    • Serum phosphate levels and risk of infection in incident dialysis patients
    • Plantinga LC, Fink NE, MelamedML et al. Serum phosphate levels and risk of infection in incident dialysis patients. Clin J Am Soc Nephrol 2008; 3: 1398-1406
    • (2008) Clin J Am Soc Nephrol , vol.3 , pp. 1398-1406
    • Plantinga, L.C.1    Fink, N.E.2    Melamed, M.L.3
  • 9
    • 0035818258 scopus 로고    scopus 로고
    • Vascular calcification in chronic renal failure
    • Goodman WG. Vascular calcification in chronic renal failure. Lancet 2001; 358: 1115-1116
    • (2001) Lancet , vol.358 , pp. 1115-1116
    • Goodman, W.G.1
  • 10
    • 72049126357 scopus 로고    scopus 로고
    • High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression
    • Roman-Garcia P, Carrillo-Lopez N, Fernandez-Martin JL et al. High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression. Bone 2010; 46: 121-128
    • (2010) Bone , vol.46 , pp. 121-128
    • Roman-Garcia, P.1    Carrillo-Lopez, N.2    Fernandez-Martin, J.L.3
  • 11
    • 79953281956 scopus 로고    scopus 로고
    • Cardiovascular risk factors in chronic kidney disease: Does phosphate qualify?
    • Hruska K, Mathew S, Lund R et al. Cardiovascular risk factors in chronic kidney disease: does phosphate qualify? Kidney Int 2011; 79 (suppl 121): S9-S13
    • (2011) Kidney Int , vol.79 , pp. S9-S13
    • Hruska, K.1    Mathew, S.2    Lund, R.3
  • 12
    • 33845916272 scopus 로고    scopus 로고
    • High dietary phosphate intake reduces bone strength in the growing rat skeleton
    • Huttunen MM, Tillman I, Viljakainen HTet al. High dietary phosphate intake reduces bone strength in the growing rat skeleton. J Bone Miner Res 2007; 22: 83-92
    • (2007) J Bone Miner Res , vol.22 , pp. 83-92
    • Huttunen, M.M.1    Tillman, I.2    Viljakainen, H.T.3
  • 13
    • 66149157312 scopus 로고    scopus 로고
    • Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function tomoderate kidney disease in MESA
    • Ix JH, De Boer IH, Peralta CA et al. Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function tomoderate kidney disease in MESA. Clin J Am Soc Nephrol 2009; 4: 609-615
    • (2009) Clin J Am Soc Nephrol , vol.4 , pp. 609-615
    • Ix, J.H.1    De Boer, I.H.2    Peralta, C.A.3
  • 14
    • 84873410543 scopus 로고    scopus 로고
    • High phosphate directly affects endothelial function by downregulating annexin II
    • Di Marco GS, Konig M, Stock C et al. High phosphate directly affects endothelial function by downregulating annexin II. Kidney Int 2013; 83: 213-222
    • (2013) Kidney Int , vol.83 , pp. 213-222
    • Di Marco, G.S.1    Konig, M.2    Stock, C.3
  • 15
    • 59949091183 scopus 로고    scopus 로고
    • Serum phosphorus levels associate with coronary atherosclerosis in young adults
    • Foley RN, Collins AJ, Herzog CA et al. Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol 2009; 20: 397-404
    • (2009) J Am Soc Nephrol , vol.20 , pp. 397-404
    • Foley, R.N.1    Collins, A.J.2    Herzog, C.A.3
  • 16
    • 59949102335 scopus 로고    scopus 로고
    • Association of serum phosphate with vascular and valvular calcification in moderate CKD
    • Adeney KL, Siscovick DS, Ix JH et al. Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol 2009; 20: 381-387
    • (2009) J Am Soc Nephrol , vol.20 , pp. 381-387
    • Adeney, K.L.1    Siscovick, D.S.2    Ix, J.H.3
  • 17
    • 34248551943 scopus 로고    scopus 로고
    • Phosphorus comes of age as a cardiovascular risk factor
    • Foley RN. Phosphorus comes of age as a cardiovascular risk factor. Arch Intern Med 2007; 167: 873-874
    • (2007) Arch Intern Med , vol.167 , pp. 873-874
    • Foley, R.N.1
  • 18
    • 33845700085 scopus 로고    scopus 로고
    • Prevalence of abnormal serum Vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease
    • Levin A, Bakris GL, MolitchMet al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 2007; 71: 31-38
    • (2007) Kidney Int , vol.71 , pp. 31-38
    • Levin, A.1    Bakris, G.L.2    Molitch, M.3
  • 19
    • 84877027844 scopus 로고    scopus 로고
    • Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease
    • Hill KM, Martin BR,Wastney ME et al. Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease. Kidney Int 2013; 83: 959-966
    • (2013) Kidney Int , vol.83 , pp. 959-966
    • Hill, K.M.1    Martin, B.R.2    Wastney, M.E.3
  • 21
    • 9644298257 scopus 로고    scopus 로고
    • Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro
    • Yang H, Curinga G, Giachelli CM. Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro. Kidney Int 2004; 66: 2293-2299
    • (2004) Kidney Int , vol.66 , pp. 2293-2299
    • Yang, H.1    Curinga, G.2    Giachelli, C.M.3
  • 22
    • 84858038439 scopus 로고    scopus 로고
    • Mortality in kidney disease patients treated with phosphate binders: A randomized study
    • Di Iorio B, Bellasi A, Russo D. Mortality in kidney disease patients treated with phosphate binders: A randomized study. Clin J Am Soc Nephrol 2012; 7: 487-493
    • (2012) Clin J Am Soc Nephrol , vol.7 , pp. 487-493
    • Di Iorio, B.1    Bellasi, A.2    Russo, D.3
  • 24
    • 84866366740 scopus 로고    scopus 로고
    • Update on fibroblast growth factor 23 in chronic kidney disease
    • Wolf M. Update on fibroblast growth factor 23 in chronic kidney disease. Kidney Int 2012; 82: 737-747
    • (2012) Kidney Int , vol.82 , pp. 737-747
    • Wolf, M.1
  • 25
    • 3543139492 scopus 로고    scopus 로고
    • Mineral metabolism, mortality, and morbidity in maintenance hemodialysis
    • Block GA, Klassen PS, Lazarus JM et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004; 15: 2208-2218
    • (2004) J Am Soc Nephrol , vol.15 , pp. 2208-2218
    • Block, G.A.1    Klassen, P.S.2    Lazarus, J.M.3
  • 26
    • 9644276844 scopus 로고    scopus 로고
    • Vascular calcification mechanisms
    • Giachelli CM. Vascular calcification mechanisms. J Am Soc Nephrol 2004; 15: 2959-2964
    • (2004) J Am Soc Nephrol , vol.15 , pp. 2959-2964
    • Giachelli, C.M.1
  • 27
    • 33646157733 scopus 로고    scopus 로고
    • Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification
    • Li X, Yang HY, Giachelli CM. Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res 2006; 98: 905-912
    • (2006) Circ Res , vol.98 , pp. 905-912
    • Li, X.1    Yang, H.Y.2    Giachelli, C.M.3
  • 29
    • 0037835949 scopus 로고    scopus 로고
    • BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure
    • Davies MR, Lund RJ, Hruska KA. BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure. J Am Soc Nephrol 2003; 14: 1559-1567
    • (2003) J Am Soc Nephrol , vol.14 , pp. 1559-1567
    • Davies, M.R.1    Lund, R.J.2    Hruska, K.A.3
  • 30
    • 33644849893 scopus 로고    scopus 로고
    • Vascular calcification and cardiovascular function in chronic kidney disease
    • SigristM, Bungay P, TaalMWet al. Vascular calcification and cardiovascular function in chronic kidney disease. Nephrol Dial Transplant 2006; 21: 707-714
    • (2006) Nephrol Dial Transplant , vol.21 , pp. 707-714
    • Sigrist, M.1    Bungay, P.2    Taal, M.W.3
  • 31
    • 0037792116 scopus 로고    scopus 로고
    • Coronary artery, aortic wall, and valvular calcification in nondialyzed individuals with type 2 diabetes and renal disease
    • Merjanian R, Budoff M, Adler S et al. Coronary artery, aortic wall, and valvular calcification in nondialyzed individuals with type 2 diabetes and renal disease. Kidney Int 2003; 64: 263-271
    • (2003) Kidney Int , vol.64 , pp. 263-271
    • Merjanian, R.1    Budoff, M.2    Adler, S.3
  • 32
    • 77954090037 scopus 로고    scopus 로고
    • Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients
    • Nasrallah MM, El-Shehaby AR, Salem MM et al. Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients. Nephrol Dial Transplant 2010; 25: 2679-2685
    • (2010) Nephrol Dial Transplant , vol.25 , pp. 2679-2685
    • Nasrallah, M.M.1    El-Shehaby, A.R.2    Salem, M.M.3
  • 33
    • 84893488379 scopus 로고    scopus 로고
    • Fibroblast growth factor-23 and cardiovascular events in CKD
    • Scialla JJ, Xie H, Rahman M et al. Fibroblast growth factor-23 and cardiovascular events in CKD. J Am Soc Nephrol 2014; 25: 349-360
    • (2014) J Am Soc Nephrol , vol.25 , pp. 349-360
    • Scialla, J.J.1    Xie, H.2    Rahman, M.3
  • 34
    • 84888348838 scopus 로고    scopus 로고
    • Use of phosphate-binding agents is associated with a lower risk of mortality
    • Cannata-Andia JB, Fernandez-Martin JL, Locatelli F et al. Use of phosphate-binding agents is associated with a lower risk of mortality. Kidney Int 2013; 84: 998-1008
    • (2013) Kidney Int , vol.84 , pp. 998-1008
    • Cannata-Andia, J.B.1    Fernandez-Martin, J.L.2    Locatelli, F.3
  • 35
    • 84897839170 scopus 로고    scopus 로고
    • Cosmos: Abnormalities in the main bone andmineral biochemical parameters are associated with higher risk of mortality
    • Fernández-Martín J, London G, Gorriz JL et al. Cosmos: abnormalities in the main bone andmineral biochemical parameters are associated with higher risk of mortality. Nephrol Dial Transplant 2013; 28 (Suppl 1): i25-i26
    • (2013) Nephrol Dial Transplant , vol.28 , pp. i25-i26
    • Fernández-Martín, J.1    London, G.2    Gorriz, J.L.3
  • 36
    • 84864859705 scopus 로고    scopus 로고
    • Effects of phosphate binders in moderate CKD
    • Block GA, Wheeler DC, Persky MS et al. Effects of phosphate binders in moderate CKD. J Am Soc Nephrol 2012; 23: 1407-1415
    • (2012) J Am Soc Nephrol , vol.23 , pp. 1407-1415
    • Block, G.A.1    Wheeler, D.C.2    Persky, M.S.3
  • 37
    • 79951895648 scopus 로고    scopus 로고
    • Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease
    • Moe SM, Zidehsarai MP, Chambers MA et al. Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol 2011; 6: 257-264
    • (2011) Clin J Am Soc Nephrol , vol.6 , pp. 257-264
    • Moe, S.M.1    Zidehsarai, M.P.2    Chambers, M.A.3
  • 38
    • 84872246782 scopus 로고    scopus 로고
    • Responsiveness of FGF-23 and mineral metabolism to altered dietary phosphate intake in chronic kidney disease (CKD): Results of a randomized trial
    • SigristM, Tang M, BeaulieuMet al. Responsiveness of FGF-23 and mineral metabolism to altered dietary phosphate intake in chronic kidney disease (CKD): results of a randomized trial. Nephrol Dial Transplant 2013; 28: 161-169
    • (2013) Nephrol Dial Transplant , vol.28 , pp. 161-169
    • Sigrist, M.1    Tang, M.2    Beaulieu, M.3
  • 39
    • 84883243996 scopus 로고    scopus 로고
    • Phosphate homeostasis in CKD: Report of a scientific symposium sponsored by the National Kidney Foundation
    • Block GA, Ix JH, KettelerMet al. Phosphate homeostasis in CKD: report of a scientific symposium sponsored by the National Kidney Foundation. Am J Kidney Dis 2013; 62: 457-473
    • (2013) Am J Kidney Dis , vol.62 , pp. 457-473
    • Block, G.A.1    Ix, J.H.2    Ketteler, M.3
  • 40
    • 0036310682 scopus 로고    scopus 로고
    • Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
    • Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002; 62: 245-252
    • (2002) Kidney Int , vol.62 , pp. 245-252
    • Chertow, G.M.1    Burke, S.K.2    Raggi, P.3
  • 41
    • 35349004713 scopus 로고    scopus 로고
    • Effects of sevelamer and calciumbased phosphate binders on mortality in hemodialysis patients
    • Suki WN, Zabaneh R, Cangiano JL et al. Effects of sevelamer and calciumbased phosphate binders on mortality in hemodialysis patients. Kidney Int 2007; 72: 1130-1137
    • (2007) Kidney Int , vol.72 , pp. 1130-1137
    • Suki, W.N.1    Zabaneh, R.2    Cangiano, J.L.3
  • 42
    • 33847223412 scopus 로고    scopus 로고
    • Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients
    • Block GA, Raggi P, Bellasi A et al. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 2007; 71: 438-441
    • (2007) Kidney Int , vol.71 , pp. 438-441
    • Block, G.A.1    Raggi, P.2    Bellasi, A.3
  • 43
    • 84884532581 scopus 로고    scopus 로고
    • Sevelamer versus calcium carbonate in incident hemodialysis patients: Results of an open-label 24-month randomized clinical trial
    • Di Iorio B, Molony D, Bell C et al. Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial. Am J Kidney Dis 2013; 62: 771-778
    • (2013) Am J Kidney Dis , vol.62 , pp. 771-778
    • Di Iorio, B.1    Molony, D.2    Bell, C.3
  • 44
    • 84901350961 scopus 로고    scopus 로고
    • REFOS study: Efficacy and safety of lanthanum carbonate in clinical practice in Spain
    • Torregrosa JV, Gonzalez-Parra E, GonzalezMTet al. REFOS study: efficacy and safety of lanthanum carbonate in clinical practice in Spain. Nefrologia 2014; 34: 360-368
    • (2014) Nefrologia , vol.34 , pp. 360-368
    • Torregrosa, J.V.1    Gonzalez-Parra, E.2    Gonzalez, M.T.3
  • 45
    • 79953033976 scopus 로고    scopus 로고
    • Effect of lanthanum carbonate treatment on bone in Japanese dialysis patients with hyperphosphatemia
    • Shigematsu T, Tokumoto A, Nakaoka A et al. Effect of lanthanum carbonate treatment on bone in Japanese dialysis patients with hyperphosphatemia. Ther Apher Dial 2011; 15: 176-184
    • (2011) Ther Apher Dial , vol.15 , pp. 176-184
    • Shigematsu, T.1    Tokumoto, A.2    Nakaoka, A.3
  • 46
    • 84887339745 scopus 로고    scopus 로고
    • Effect of calcium-based versus noncalcium-based phosphate binders on mortality in patients with chronic kidney disease: An updated systematic review and meta-analysis
    • Jamal SA, Vandermeer B, Raggi P et al. Effect of calcium-based versus noncalcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet 2013; 382: 1268-1277
    • (2013) Lancet , vol.382 , pp. 1268-1277
    • Jamal, S.A.1    Vandermeer, B.2    Raggi, P.3
  • 47
    • 78650315397 scopus 로고    scopus 로고
    • Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: A controlled randomized study (CALMAG study) assessing efficacy and tolerability
    • de Francisco AL, Leidig M, Covic AC et al. Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: A controlled randomized study (CALMAG study) assessing efficacy and tolerability. Nephrol Dial Transplant 2010; 25: 3707-3717
    • (2010) Nephrol Dial Transplant , vol.25 , pp. 3707-3717
    • De Francisco, A.L.1    Leidig, M.2    Covic, A.C.3
  • 48
    • 84884509947 scopus 로고    scopus 로고
    • A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: Post hoc evaluation from a controlled, randomized study
    • Covic A, Passlick-Deetjen J, Kroczak M et al. A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study. Nephrol Dial Transplant 2013; 28: 2383-2392
    • (2013) Nephrol Dial Transplant , vol.28 , pp. 2383-2392
    • Covic, A.1    Passlick-Deetjen, J.2    Kroczak, M.3
  • 49
    • 84875035936 scopus 로고    scopus 로고
    • Randomized clinical trial of the iron-based phosphate binder PA21 in hemodialysis patients
    • Wuthrich RP, Chonchol M, Covic A et al. Randomized clinical trial of the iron-based phosphate binder PA21 in hemodialysis patients. Clin J AmSoc Nephrol 2013; 8: 280-289
    • (2013) Clin J AmSoc Nephrol , vol.8 , pp. 280-289
    • Wuthrich, R.P.1    Chonchol, M.2    Covic, A.3
  • 50
    • 84899827376 scopus 로고    scopus 로고
    • A randomized trial of JTT-751 versus sevelamer hydrochloride in patients on hemodialysis
    • Yokoyama K, Akiba T, Fukagawa M et al. A randomized trial of JTT-751 versus sevelamer hydrochloride in patients on hemodialysis. Nephrol Dial Transplant 2013; 29: 1-10
    • (2013) Nephrol Dial Transplant , vol.29 , pp. 1-10
    • Yokoyama, K.1    Akiba, T.2    Fukagawa, M.3
  • 51
    • 84924004431 scopus 로고    scopus 로고
    • Ferric citrate controls phosphorus and delivers iron in patients on dialysis
    • Lewis JB, Sika M, Koury MJ et al. Ferric citrate controls phosphorus and delivers iron in patients on dialysis. J Am Soc Nephrol 2015; 26: 493-503
    • (2015) J Am Soc Nephrol , vol.26 , pp. 493-503
    • Lewis, J.B.1    Sika, M.2    Koury, M.J.3
  • 52
    • 84902250298 scopus 로고    scopus 로고
    • Coupling fibroblast growth factor 23 production and cleavage: Iron deficiency, rickets, and kidney disease
    • Wolf M, White KE. Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease. Curr Opin Nephrol Hypertens 2014; 23: 411-419
    • (2014) Curr Opin Nephrol Hypertens , vol.23 , pp. 411-419
    • Wolf, M.1    White, K.E.2
  • 53
    • 37749016095 scopus 로고    scopus 로고
    • A comparative review of the efficacy and safety of established phosphate binders: Calcium, sevelamer, and lanthanum carbonate
    • Sprague SM. A comparative review of the efficacy and safety of established phosphate binders: calcium, sevelamer, and lanthanum carbonate. Curr Med Res Opin 2007; 23: 3167-3175
    • (2007) Curr Med Res Opin , vol.23 , pp. 3167-3175
    • Sprague, S.M.1
  • 54
    • 84965145158 scopus 로고    scopus 로고
    • Phosphate binders and clinical outcomes in stage 5D CKD patients
    • in press
    • Zoccali A, Mallamaci F, Cannata-Andía JB. Phosphate binders and clinical outcomes in stage 5D CKD patients. Sem Dialysis 2015 (in press)
    • (2015) Sem Dialysis
    • Zoccali, A.1    Mallamaci, F.2    Cannata-Andía, J.B.3
  • 55
    • 84891559221 scopus 로고    scopus 로고
    • AMG 416 (velcalcetide) is a novel peptide for the treatment of secondary hyperparathyroidism in a singledose study in hemodialysis patients
    • Martin KJ, Pickthorn K, Huang S et al. AMG 416 (velcalcetide) is a novel peptide for the treatment of secondary hyperparathyroidism in a singledose study in hemodialysis patients. Kidney Int 2014; 85: 191-197
    • (2014) Kidney Int , vol.85 , pp. 191-197
    • Martin, K.J.1    Pickthorn, K.2    Huang, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.